BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE: KG) announced today the appointment of Eric G. Carter as the Company’s Chief Science Officer. Dr. Carter will oversee all of King’s research and development, regulatory and medical affairs activities.
